Afreen Shariff, MD, MBBS, examines the surveillance and management of immunotherapy-induced adrenal insufficiency in the context of melanoma, underscoring the importance of maintaining a heightened awareness for early detection.
Nikhil Khushalani, MD, examines immunotherapy resistance in melanoma treatment, providing valuable insights into navigating challenges and its impact on treatment decisions.
Nikhil Khushalani, MD, provides a thorough exploration of the current treatment landscape in adjuvant therapy for melanoma, presenting insights into advancing strategies and developments in the field, while also discussing key findings from the Checkmate-238 and KEYNOTE-054 trials.